- Home
- Our company
Our company
At Johnson & Johnson, we believe health is everything. Every day, our approximately 140,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. For 140 years, we have aimed to keep people well at every age and every stage of life.
We’re tackling the world’s toughest health challenges
We innovate across the full spectrum of healthcare solutions today to uniquely position us for the breakthroughs of tomorrow. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, there are specific areas where we uniquely impact health in a way that only we can.
J&J Innovative Medicine
Johnson & Johnson Innovative Medicine is leading where medicine is going.
Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the medicines of tomorrow.
Our diverse product portfolio spans multiple areas, where patient need is high and our expertise is deep:
Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the medicines of tomorrow.
Our diverse product portfolio spans multiple areas, where patient need is high and our expertise is deep:
- Oncology
- Immunology
- Neuroscience
- Cardiopulmonary
J&J MedTech
Johnson & Johnson MedTech innovates at the intersection of biology and technology.
With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges.
We’re reimagining the way healthcare is delivered and helping people live longer, healthier lives in these four areas:
With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges.
We’re reimagining the way healthcare is delivered and helping people live longer, healthier lives in these four areas:
- Cardiovascular
- Orthopaedics
- Surgery
- Vision
Our leaders
Joaquin Duato
Chairman and Chief Executive Officer
As CEO of the world’s largest healthcare company, Joaquin Duato leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health.
Our people
We believe we can solve the world’s toughest health challenges, and innovate and improve the lives of patients only when we have the best people on our teams.
Looking to be part of our mission? Learn more about careers at J&J.
Looking to be part of our mission? Learn more about careers at J&J.
Our rich history of innovation
140 years of pioneering in healthcare
We believe good health is the foundation of vibrant lives, thriving communities and progress. That’s why since 1886, we have aimed to keep people well at every age and every stage of life. Learn about our history.
8 decades of Our Credo
The values that guide our decision-making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.
J&J at a glance
≈140,000
Dedicated employees worldwide
70
novel therapies and/or product expansions by 2030
64
Manufacturing facilities around the globe
Our stories of impact
3 nurse practitioners who are filling critical gaps in healthcare
From using cutting-edge technology to address mental health issues to launching an urban clinic that helps treat substance-abuse disorders and taking an innovative approach to deliver rural medical care, learn how Johnson & Johnson is helping support a new generation of providers.
What is a gene mutation?
Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. Learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.
“Reimagining what life with schizophrenia could look like”
Johnson & Johnson’s Leonardo Diaz, M.D., addresses common misconceptions about schizophrenia, the critical importance of preventing relapse and why there’s so much optimism about treatments.
What you need to know about Johnson & Johnson’s first-quarter 2026 earnings report
Check out this infographic breakdown of the company’s first-quarter performance, with highlights from its Innovative Medicine and MedTech businesses.
Giving the gift of sight
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.
What are cataracts?
Cataracts are the most common cause of vision loss worldwide. Luckily a routine surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.